Abstract
Introduction

33
The pharmaceutical industry has progressively shifted its focus from small chemical drugs 34 towards the use of large biomolecules such as antibodies. In order to scale-up the 35 manufacture of biopharmaceuticals and produce them at a greater efficiency, product-specific 36 titres have increased steadily over the past three decades from less than 0.5 g/L in the early 37 1990s to values in excess of 3 g/L for newer processes, with 7 g/L and above being the new 38 top-end industry target [1] . This order of magnitude increase has moved the production Micro-capillary films (MCFs) aim to provide a low-cost technology for protein separations 51 [7] . Composed of a continuous capillary array embedded into an ethylene-vinyl alcohol 52 (EVOH) film matrix, these membranes have the potential for use in direct capture of proteins 53 from unfiltered cell lysate. MCFs can be extruded as a non-porous (NMCFs) film using melt 54 extrusion [8] or a porous (MMCFs) film using non-solvent induced phase separation (NIPS) 55 [9]. Benefits of this technology include its ease of manufacture and scale-up (tubular 56 configuration), its low cost (~ 50 pence/metre for MCF manufacture) [7] and the high 57 superficial velocities through the membrane lumen which can be attained (greater than 5000 58 cm/h) [10] . Moreover, the hydroxyl-rich nature of the polymer allows for a wide-range of MMCFs were produced using protocols described previously [9] [10]. Briefly, polymer 
106
Chemical modification of MMCFs with DEAE
107
The coupling of 2-diethylaminoethylamine (DEAE) onto the MMCF backbone was achieved The chemical modification is summarised in Fig. 1 The ion exchange capacity was determined using a modified protocol from Karas et al. [14] . used to indicate when all the Cl -had been exhausted from the supernatant.
134
Experiments were repeated in triplicate with unmodified MMCF used as a control. MMCFs was determined by mass balance and, all experiments were repeated in triplicate. hours and quantified using a Bradford assay.
154
Experiments were repeated in triplicate and unmodified MMCF was used as a control. Eqs.
(1) was used to calculate the mass of BSA eluted at increasing loading concentration.
172
Where C inj is the concentration of protein used at injection.
173
The data was fitted to a Langmuir isotherm adsorption model, described according to Eqs. Frontal analysis experiments using BSA were conducted from pH 6.2 to pH 9.2 to determine 
188
Experiments were repeated in triplicate and the mass of BSA eluted was calculated using
189
Eqs. (1) .
190
The effect of flowrate on binding was determined using 100 μL pulse injections of 191 BSA (5 mg/mL) onto MMCF-DEAE. The capture (%) was calculated using Eqs. (3):
193
Flowrates between 0.1 mL/min and 10 mL/min were tested to keep the pressure drop below ~ The ability to separate two anionic molecules was tested using 100 μL injections of BSA (5 212 mg/mL) and herring sperm DNA (0.25 mg/mL) onto a 20 cm MMCF-DEAE column. A two- and, a bimodal pore size distribution (PSD) centred at 1000 nm and 100 000 nm in diameter 228 (see Fig. 3B ) was observed. Fig. 2A suggests that, the larger "pores" corresponded to the 229 central capillaries, defects and macrovoids whereas the pores between 150 nm and 3000 nm 230 were representative of the PSD within the membrane film.
231
FTIR spectra of unmodified MMCF and MMCF-DEAE revealed the presence of two 232 additional peaks at 1578 cm -1 and 1547 cm -1 for MMCF-DEAE (see Fig. 4 than an order of magnitude lower than that achieved with commercial membranes [20] .
248
The binding of BSA onto MMCF-DEAE was found to increase linearly during the first 8
249
hours (see Fig. 6 ) prior to reaching a plateau at the 12 hour mark due to binding site 250 saturation. After 24 hours, a maximum binding was reached of 10 mg BSA/mL adsorbent, in-
251
line with the previously observed maximum binding of 10 mg BSA/mL adsorbent at 1 mg 252 BSA/mL loading (Fig. 5A) . to diffuse into the membrane matrix.
265
The effect of pH on binding under flow condition is shown in Fig. 7 . As the pH was 266 increased from pH 6.2 to 9.2, a sharper breakthrough curve (Fig. 7A) during the loading step 267 was obtained indicating that less mass was bound to the column. This was verified in the 268 elution step (Fig. 7B) where, the largest elution area was obtained at pH 6.2 corresponding to 269 a binding of 7.7 mg BSA/mL adsorbent. Further increase in pH resulted in diminished 270 binding and, at pH 9.2 the elution peak was below detection limit (Fig. 7C) . This behaviour The separation of BSA from a lysozyme containing mixture is shown in Fig. 9 . It can be 300 seen that BSA was successfully recovered at high purity as determined by SDS-PAGE 301 analysis of the elution (Fig. 9B) . A faint lysozyme band below the limit of quantification was 
310
The separation of two anionic molecules, fish sperm DNA and BSA, onto an MMCF-DEAE 311 column was tested using a two-step NaCl elution. As can be observed in Fig. 10C , two 312 elution peaks were obtained. From the controls, Fig. 10A and Fig. 10B , the first elution 313 corresponded to a BSA dominant peak and that the second elution was DNA dominant.
314
Further analysis of the fractions collected with a commercial Mono Q 5/50 GL high- 
320
The mass of BSA recovered in the first elution peak was 0. 
